Medplus Health Services Ltd

Medplus Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Medplus Health Services Ltd

₹ 888 -0.78%
10 Jun 1:07 p.m.
medplusindia.com BSE: 543427 NSE: MEDPLUS
About
Key Points

India's Leading Pharmacy Company[1][2]
MedPlus is the 2nd largest pharmacy retailer in India, with 4,552 stores across 12 states and 1 union territory as of Q2 FY25. These stores are strategically distributed to maintain a high presence in metro, tier-one, and tier-two cities.

  • Store Distribution by Region[1]
  • Telangana: 679 stores
  • Andhra Pradesh: 454 stores
  • Karnataka: 893 stores
  • Tamil Nadu: 845 stores
  • West Bengal: 506 stores
  • Maharashtra: 553 stores
  • Odisha: 149 stores
  • Chhattisgarh: 4 stores
  • Madhya Pradesh: 4 stores
  • Puducherry: 5 stores
  • Delhi: 1 store

The stores increased with 108 net new stores added in Q2 FY2025, of which 71 were in Tier-2 and Tier-3 cities[3]

Website BSE NSE
  • Market Cap ₹ 10,628 Cr.
  • Current Price ₹ 888
  • High / Low ₹ 1,052 / 603
  • Stock P/E 263
  • Book Value ₹ 104
  • Dividend Yield 0.00 %
  • ROCE 4.61 %
  • ROE 3.34 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 29.4% CAGR over last 5 years
  • Company's median sales growth is 46.8% of last 10 years

Cons

  • Stock is trading at 8.64 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 1.58% over last 3 years.
  • Promoters have pledged 59.3% of their holding.
  • Working capital days have increased from 53.1 days to 79.5 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Retailing Pharmacy Retail

Part of BSE 500 BSE SmallCap BSE Allcap BSE Consumer Discretionary BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
39 27 42 57 87 72 99 148 148 178 156 177 202
41 29 43 54 76 70 92 137 135 160 139 158 178
Operating Profit -2 -2 -0 4 11 2 6 11 13 18 17 19 24
OPM % -6% -6% -1% 7% 13% 3% 6% 7% 9% 10% 11% 11% 12%
6 5 4 4 3 2 2 2 2 2 2 2 3
Interest 1 1 1 2 2 2 2 2 2 2 2 2 2
Depreciation 2 3 3 4 5 6 6 6 6 6 7 6 7
Profit before tax 1 0 -1 2 7 -3 -0 4 6 12 10 12 18
Tax % 0% 0% 0% 65% 13% 0% 0% 25% -57% 20% 20% 22% 22%
1 0 -1 1 6 -3 -0 3 10 9 8 9 14
EPS in Rs 0.08 0.00 -0.07 0.05 0.48 -0.29 -0.01 0.27 0.82 0.77 0.65 0.78 1.17
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2 2 2 9 10 61 68 146 214 467 713
6 7 4 14 13 86 77 142 208 435 635
Operating Profit -3 -5 -2 -5 -3 -25 -9 3 6 32 78
OPM % -137% -225% -89% -52% -36% -41% -13% 2% 3% 7% 11%
-1 1 0 1 1 2 2 10 23 7 9
Interest 1 0 0 12 0 0 1 3 7 8 9
Depreciation 0 0 0 0 0 1 1 5 15 24 27
Profit before tax -5 -4 -2 -16 -3 -24 -9 6 8 7 51
Tax % 0% 0% 0% 0% 0% 2% 0% 0% 27% -36% 21%
-5 -4 -2 -16 -3 -25 -9 6 6 10 40
EPS in Rs -292.30 -241.71 -109.61 -793.71 -126.23 -1,220.91 -186.95 0.47 0.46 0.80 3.37
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 77%
5 Years: 63%
3 Years: 70%
TTM: 53%
Compounded Profit Growth
10 Years: 30%
5 Years: 29%
3 Years: 95%
TTM: 326%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 6%
1 Year: 27%
Return on Equity
10 Years: 0%
5 Years: 1%
3 Years: 2%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.17 0.17 0.17 0.19 0.19 0.19 0.45 24 24 24 24
Reserves 126 108 88 185 185 395 517 1,089 1,117 1,149 1,216
55 55 55 0 0 3 7 44 86 89 95
6 21 39 3 6 17 24 30 45 51 65
Total Liabilities 187 185 183 189 192 415 548 1,187 1,272 1,312 1,399
1 1 0 0 0 7 23 85 179 192 184
CWIP 0 0 0 0 0 1 2 16 18 0 1
Investments 153 177 177 181 186 381 408 418 917 930 928
34 6 5 8 5 26 115 668 157 190 286
Total Assets 187 185 183 189 192 415 548 1,187 1,272 1,312 1,399

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-5 -4 -2 -1 -1 -0 -6 -18 11 8 47
-11 -24 0 -2 -3 -194 -15 -636 32 -24 -39
46 0 0 7 0 204 97 569 -8 -6 -10
Net Cash Flow 30 -28 -1 4 -4 10 76 -86 35 -23 -2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 32 29 14 22 80 51 62 53 64 51 62
Inventory Days 33 35 12 16 15 12
Days Payable 9 17 17 30 19 30
Cash Conversion Cycle 32 29 14 22 80 75 79 48 50 47 44
Working Capital Days -78 -72 -130 -97 -145 -11 -16 1,554 30 50 80
ROCE % -2% -1% -2% -1% -8% -2% 1% 1% 1% 5%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
40.43% 40.43% 40.43% 40.43% 40.43% 40.41% 40.45% 40.39% 40.39% 40.39% 40.39% 40.33%
3.15% 3.74% 3.94% 4.48% 4.87% 12.36% 12.96% 14.94% 14.85% 14.72% 15.23% 15.61%
29.48% 28.84% 28.77% 28.16% 28.13% 25.50% 25.19% 22.47% 22.17% 27.98% 25.66% 26.19%
26.58% 26.64% 26.56% 26.73% 26.42% 21.61% 21.31% 22.10% 22.51% 16.85% 18.68% 17.82%
0.35% 0.35% 0.29% 0.19% 0.15% 0.12% 0.10% 0.10% 0.08% 0.07% 0.05% 0.05%
No. of Shareholders 77,11976,97274,70273,51270,01766,43066,04874,97676,93487,32883,91283,439

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls